Data integrity considerations in Pharma and Life Sciences
European Pharmaceutical Review
MARCH 12, 2024
Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Lack of proper training can lead to errors, omissions, or intentional data manipulation, which can compromise data. Use of advanced technologies.
Let's personalize your content